Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: KewlHand who wrote (315)	1/14/2000 9:12:00 AM
From: Biomaven	Read Replies (2) \| Respond to of 427

KewlHand, Short squeezes are few and far between, particularly in a stock such as CLPA that has traded options. The short position (more than 5 million shares) is indeed very significant, but remember that some of it may already be hedged by option positions. CLPA is an interesting stock, but it is certainly not a $1,000 stock. People who put all their investments in a single early-stage biotech company tend not to have a very long life expectancy as biotech investors. Peter